Hunter, David JKraft, PeterJacobs, Kevin BCox, David GYeager, MeredithHankinson, Susan EWacholder, SholomWang, ZhaomingWelch, RobertHutchinson, AmyWang, JunwenYu, KaiChatterjee, NilanjanOrr, NickWillett, Walter CColditz, Graham AZiegler, Regina GBerg, Christine DBuys, Saundra SMcCarty, Catherine AFeigelson, Heather SpencerCalle, Eugenia EThun, Michael JHayes, Richard BTucker, MargaretGerhard, Daniela SFraumeni, Joseph F, JrHoover, Robert NThomas, GillesChanock, Stephen JWe conducted a genome-wide association study (GWAS) of breast cancer by genotyping 528,173 SNPs in 1,145 postmenopausal women of European ancestry with invasive breast cancer and 1,142 controls. We identified four SNPs in intron 2 of FGFR2 (which encodes a receptor tyrosine kinase and is amplified or overexpressed in some breast cancers) that were highly associated with breast cancer and confirmed this association in 1,776 affected individuals and 2,072 controls from three additional studies. Across the four studies, the association with all four SNPs was highly statistically significant (Ptrend for the most strongly associated SNP (rs1219648) = 1.1 10-10; population attributable risk = 16%). Four SNPs at other loci most strongly associated with breast cancer in the initial GWAS were not associated in the replication studies. Our summary results from the GWAS are available online in a form that should speed the identification of additional risk lociCancerResearchgenome-wide association studybreast cancerpostmenopausal womenArticle